EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Adenovirus Disease Following Pediatric Liver Transplantation: 10‐Year Experience From a Large Pediatric Transplant Program

Anna M Banc-Husu iD, Sara Hassan iD, N Thao N Galvan iD, Elizabeth A Moulton iD, Jeremy M Schraw iD, Kathleen Hosek, Dana Cerminara, Flor M Munoz iD, Krupa Mysore iD

Pediatric Transplantation · 2026

DOI: 10.1111/petr.70298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Anna M Banc-Husu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital,…. Hauptthemen laut MEDLINE: Liver Transplantation, Postoperative Complications, Adenovirus Infections, Human, Adenoviridae Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human adenovirus in immunocompromised patients can be life‐threatening. We describe the prevalence, clinical presentation, and treatment of adenovirus after pediatric liver transplantation at a large transplant center.

Methods

We performed a retrospective cohort study of adenovirus infection in children from 2013 to 2022. We compared incidence, clinical characteristics, and outcomes of post‐transplant children by adenovirus treatment status.

Results

Adenovirus disease developed in 26% (84/320) children after liver transplant. Median age at liver transplant was 17.5 months, 48% were female; 50% had biliary atresia. Fever (53%), gastrointestinal symptoms (48%), and hepatitis (41%) were the most common clinical presentations at diagnosis. Median time to adenovirus diagnosis was 80 days (IQR 19–260) with 40% ( n = 31/84) identified within 30 days post‐transplant. Disseminated adenovirus (≥ 2 organ involvement) occurred in 24% (20/84). Fourteen patients (17%) received cidofovir, and most (13/14, 93%) had DNAemia, compared to 57% untreated patients with DNAemia ( p = 0.013). Median peak adenovirus load was 491 805 copies/mL (IQR 24 800–1 900 000) in treated vs. 1000 copies/mL (IQR 595–794 794) in untreated patients ( p < 0.001). Overall mortality was 8% (7/84).

Conclusion

The incidence of symptomatic and disseminated adenovirus disease was high in our pediatric liver transplant patients, particularly within 30 days post‐transplant. Patients who received cidofovir treatment presented with high viral load and had the highest mortality. There is a critical need for evidence‐based guidance for early antiviral management of adenovirus disease after pediatric liver transplant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationPostoperative ComplicationsAdenovirus Infections, HumanAdenoviridae InfectionsHumansFemaleRetrospective StudiesInfantMaleChild, PreschoolChildAntiviral AgentsIncidencePrevalenceImmunocompromised Host

Stichwörter der Autor:innen

adenovirus diseaseadenovirus infectioncidofovirdisseminated adenoviruspediatric liver transplant

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
  • Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of Texas Southwestern, Children's Health, Dallas, Texas, USA.
  • Division of Abdominal Transplantation, Michael E. De Bakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
  • Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
  • Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Pediatrics, Division of Quality Outcomes and Analytics, Texas Children's Hospital, Houston, Texas, USA.

ORCID-Profile: Anna M Banc-Husu, Sara Hassan, N Thao N Galvan, Elizabeth A Moulton, Jeremy M Schraw, Flor M Munoz, Krupa Mysore

Zitieren

APA

Banc-Husu, A. M., Hassan, S., Galvan, N. T. N., Moulton, E. A., Schraw, J. M., Hosek, K., Cerminara, D., Munoz, F. M., & Mysore, K. (2026). Adenovirus Disease Following Pediatric Liver Transplantation: 10‐Year Experience From a Large Pediatric Transplant Program. Pediatric Transplantation. https://doi.org/10.1111/petr.70298

Vancouver

Banc-Husu AM, Hassan S, Galvan NTN, Moulton EA, Schraw JM, Hosek K, et al. Adenovirus Disease Following Pediatric Liver Transplantation: 10‐Year Experience From a Large Pediatric Transplant Program. Pediatric Transplantation. 2026. doi:10.1111/petr.70298

BibTeX
@article{BancHusu2026,
  author = {Banc-Husu, Anna M and Hassan, Sara and Galvan, N Thao N and Moulton, Elizabeth A and Schraw, Jeremy M and Hosek, Kathleen and Cerminara, Dana and Munoz, Flor M and Mysore, Krupa},
  title = {Adenovirus Disease Following Pediatric Liver Transplantation: 10‐Year Experience From a Large Pediatric Transplant Program},
  journal = {Pediatric Transplantation},
  year = {2026},
  doi = {10.1111/petr.70298}
}
Kostenlos starten →